Suppr超能文献

首例报道的导致越南患者全羧化酶合成酶缺乏症的 HLCS 基因突变。

The first reported HLCS gene mutation causing holocarboxylase synthetase deficiency in a Vietnamese patient.

机构信息

Department of Pediatrics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.

出版信息

World J Pediatr. 2012 Aug;8(3):278-80. doi: 10.1007/s12519-011-0301-9. Epub 2011 Aug 27.

Abstract

BACKGROUND

Holocarboxylase synthetase deficiency is an inborn error of biotin metabolism leading to multiple carboxylase deficiency which is often biotin responsive. This disease is believed to be relatively common among the Asian population.

METHODS

A 6-year-old Vietnamese boy presented with recurrent episodes of severe metabolic acidosis precipitated by intercurrent illnesses. An extensive skin rash was present since the onset of his illness. Multiple carboxylase deficiency was considered a likely diagnosis based on the history and the characteristic skin rash.

RESULTS

This diagnosis was later confirmed by urine organic acid and molecular genetic studies. Urine organic acid showed characteristic excretion of glycine conjugates. Serum biotinidase activity was normal. Sequencing of the holocarboxylase synthetase gene revealed the patient being homozygous for a common mutation R508W. The patient showed a dramatic response to biotin within days of its administration.

CONCLUSION

This case illustrates a potential highly treatable inborn error of metabolism that can be recognized on clinical grounds and its favorable response to biotin treatment.

摘要

背景

全羧化酶合成酶缺乏症是一种生物素代谢的先天性错误,导致多种羧化酶缺乏,这通常对生物素有反应。据信,这种疾病在亚洲人群中较为常见。

方法

一名 6 岁越南男孩因并发疾病反复发作严重代谢性酸中毒而就诊。自发病以来,他一直存在广泛的皮疹。根据病史和特征性皮疹,多羧化酶缺乏症被认为是一种可能的诊断。

结果

该诊断后来通过尿液有机酸和分子遗传学研究得到证实。尿液有机酸显示出特征性的甘氨酸缀合物排泄。血清生物酶活性正常。全羧化酶合成酶基因的测序显示患者为常见突变 R508W 的纯合子。患者在接受生物素治疗后几天内就出现了显著的反应。

结论

本病例说明了一种潜在的可治疗的代谢性先天性错误,可根据临床情况识别,并对生物素治疗有良好的反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验